Gilbert Ray Cisneros, Jr. bought PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH)
Gilbert Ray Cisneros, Jr. (D-CA), a U.S. Representative, has disclosed 4 trades in PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH) since 2020, all purchases, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Gilbert Ray Cisneros, Jr. bought $1,001 - $15,000 of PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH) on November 3, 2020. Since that trade, PRAH is up +0.00% against the S&P 500 up +134.19%, an outperformance of -134.19%.
Across these filings, Gilbert Ray Cisneros, Jr. has been a net buyer of PRAH. The most recent disclosed PRAH transaction shown was dated November 6, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Gilbert Ray Cisneros, Jr.'s PRAH trades vs the price
PRAH is up +0.00% since Gilbert Ray Cisneros, Jr. bought on November 3, 2020, versus +134.19% for the S&P 500.
Performance since this trade
All Gilbert Ray Cisneros, Jr. PRAH trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| November 6, 2020 | BUY | $1,001 - $15,000 | N/A | — | |
| November 5, 2020 | BUY | $1,001 - $15,000 | N/A | — | |
| November 4, 2020 | BUY | $1,001 - $15,000 | N/A | — | |
| November 3, 2020 | BUY | $1,001 - $15,000 | N/A | — |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Gilbert Ray Cisneros, Jr. & PRAH trading FAQ
Is it legal for Gilbert Ray Cisneros, Jr. to trade PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH) stock?
Yes. Members of Congress are allowed to trade individual stocks, including PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Gilbert Ray Cisneros, Jr. buy PRAH?
Gilbert Ray Cisneros, Jr. disclosed a purchase of $1,001 - $15,000 of PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH) on November 3, 2020, according to public STOCK Act filings.
How has PRAH performed since Gilbert Ray Cisneros, Jr.'s trade?
Since Gilbert Ray Cisneros, Jr. bought PRAH on November 3, 2020, the stock is up +0.00%, versus +134.19% for the S&P 500 over the same period, an outperformance of -134.19%.
How many times has Gilbert Ray Cisneros, Jr. traded PRAH?
Gilbert Ray Cisneros, Jr. has disclosed 4 PRAH trades since 2020. Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional PRAH trades?
Quantellect tracks every disclosed congressional trade in PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings (PRAH) on the PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust Holdings congressional trading page, which aggregates filings across all members of Congress.
Gilbert Ray Cisneros, Jr.'s PRAH tradesAll congressional filings for PRA Health Sciences, Inc. (PRAH) [ST] F ILING S TATUS : New S UbHOLdING O F : 150 Main Street Trust > U.S. Trust HoldingsGilbert Ray Cisneros, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.